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ABSTRACT
Background and aims: The major risk factors for acute
hepatitis B (AHB) in China and the viral factors
determining the progression from acute to chronic
hepatitis B remain largely unknown.
Methods: Epidemiological studies within a population-
based surveillance for AHB in adults were performed in
Shanghai, China, including 294 patients, 588 matched
controls and 572 family members of the patients.
Results: Invasive medical procedures, household contact
with hepatitis B virus (HBV) carriers, body care and
beauty treatments, and lack of HBV vaccination were
independently associated with AHB. Among those risks,
pedicure in bath centres emerged. Sixty-eight of 128
patients with AHB were genotyped including 33 with HBV
B2 and 35 with HBV C2. Twenty-five (8.50%) of the 294
patients, including 20 with HBV C2 and 5 with HBV B2
(p=0.013), progressed to chronic infection. Multivariate
analysis showed that HBV C2 was independently
associated with chronicification of AHB. Patients with
HBV B2 were younger and there was a higher proportion
of women than those with HBV C2. The prevalence of
HBV B2 was higher in the patients than in neighbourhood
chronic carriers. The chronic carriers with HBV B2 showed
higher viral loads, higher hepatitis B e antigen (HBeAg)
seropositivity, and with higher proportion in men than
those with HBV C2, implying that sexual contact plays a
role in the transmission of HBV B2. Phylogenetic analysis
showed that HBV C2 was frequently involved in
transmissions within households.
Conclusions: Despite lower viral load and HBeAg status
in the chronic carriers, HBV C2 was more prone to
causing chronic infection than was HBV B2.
Infection with hepatitis B virus (HBV) is a major
global health problem. Approximately 3 billion
people have been exposed to HBV, and more than
300 million are chronically infected with HBV.
12In
HBV non-endemic areas, most HBV infections are
transmitted during adolescence or adulthood:
sexual intercourse, use of injectable drugs, and
nosocomial infection are risk factors for acute
hepatitis B (AHB).
3–5 Approximately 45% of the
world’s population lives in regions where HBV
infection is endemic.
2 In the endemic areas, HBV
infections frequently occur in the neonatal period
or during early childhood, but very few studies on
risk factors for AHB in adults have been reported.
In mainland China, an endemic area with one-
third of the world’s HBV carriers, HBV transmis-
sion in the neonatal period used to be a major
route.
6 After nationwide HBV vaccination in new-
borns was implemented in 1992, the prevalence
of HBV in children decreased dramatically. A
nationwide survey in 2006 showed that the
prevalence of hepatitis B surface antigen
(HBsAg) was around 1.5% in children under the
age of 8 years, and 7.18% in the nationwide
population at an age between 1 and 59 years
(unpublished data). In Shanghai, the annual
incidence of AHB has been documented since
1993 (fig 1). Although an overall decrease is
evident, the incidence of AHB remains high.
The natural course of HBV infection is very
distinct. An important step in the natural course of
HBV infection is the transition from acute to
chronic infection. Induction of HBV chronicity has
been shown to be influenced by the immune
system and other host factors.
78While newborns
become chronic HBV carriers at a very high rate
(about 90%), immune competent adults are gen-
erally described as developing chronic hepatitis at a
rate of 5–10%.
1 The natural course of HBV infection
and the response to therapy are affected by HBV
genotype.
9–11 To date, eight genotypes (A–H) that
differ by 8–15% at the nucleotide level have been
identified.
12 13 HBV genotypes show distinct geo-
graphic prevalence.
12–14 In Shanghai and surround-
ing areas, HBV genotypes C2 (62.1–72.9%) and B2
(13.4–28.0%) were the most prevalent genotypes
in asymptomatic HBsAg carriers (ASCs), the
patients with chronic hepatitis B and those with
hepatocellular carcinoma.
15 A contribution of viral
genotypes to the persistence of HBV was sug-
gested.
16 However, no epidemiological study with
a sufficient number of cases has shown an effect
of HBV genotypes on the rate of HBV chronicity.
In a limited number of cases, it was shown that
HBV genotype D was associated with acute liver
damage, while genotype A was associated with
chronic outcome.
17 18
A study for the establishment of HBV infection
in chimpanzees showed that dose-dependent
experimental infection led to different outcomes.
19
In a woodchuck model, high doses of woodchuck
hepatitis virus induced high rates of chronicity,
while chronicity rates were decreased for low
doses of viral infection.
20 In experimental studies
conducted in the 1950s, patients who developed
chronic hepatitis B had higher peak levels of viral
markers that appeared early during the acute
phase of infection than those with self-limited
hepatitis.
21 These observations imply that another
potential viral determinant for the chronic out-
come of AHB is the infection dose influenced by
exposure type.
To elucidate the influence of HBV genotypes on
the chronic progression of AHB, current risk
factors for AHB, and its potential impact on the
Hepatology
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Shanghai, China.
SUBJECTS AND METHODS
Pilot study
To estimate the sample size for this 1:2 case–control study, an
anonymous pilot survey of selected behaviours related to the
transmission of HBV was initially conducted in Minhang
District of Shanghai. In the population surveyed, exposure
ratios of intravenous injection/infusion, pedicure, and beauty
treatment were 12%, 14% and 5%, respectively. On the basis
of the frequency of the exposures, an alpha level of 0.05, a beta
level of 0.10, and crude odds ratio (OR) level of 2.5, it was
calculated that sample sizes of 134 cases, 120 cases, and 275
cases were needed, respectively. In this study, 294 patients
with AHB were estimated to provide statistically significant
data.
Cases and controls
Shanghai is composed of 18 administrative districts and one
affiliated county. Five administrative districts including
Songjiang, Baoshan, Pudong, Minhang and Nanhui were
selected as study districts by a simple stochastic sampling
method. AHB was diagnosed as follows: HBsAg and antibody to
hepatitis B core antigen (anti-HBc) of the immunoglobulin M
(IgM) class, acute-onset elevation (.45 U/l) of serum alanine
aminotransferase levels. To discriminate AHB by new infection
from acute exacerbation of chronic infection, the absence of
serum HBsAg and anti-HBc before admission was verified by
checking medical records. Previous negative HBsAg and anti-
HBc status, together with the persistent presence of HBsAg in
serum after an observation period of more than 6 months, was
considered as progression to chronic infection.
22 Patients with
acute hepatitis A, hepatitis E, hepatitis C virus infection and/or
co-infection, and drug- or alcohol-induced hepatitis were
excluded. During January 2004 through December 2006, 298
AHB cases with medical records showing negative HBsAg were
registered in the Centers of Disease Control and Prevention of
five districts of Shanghai. Four of the 298 patients were
excluded from the study because the controls did not match
the cases.
Control subjects matched to the cases by sex and date of birth
(within 2 years). A total of 624 candidate-matched controls
were randomly recruited from the source population from which
the cases arose at the time of AHB diagnosis. A total of 572 family
members who had lived with the patient for more than 1 year
were involved in the study. A total of 113 asymptomatic HBsAG
carriers (ASCs) from the same source population were recruited
during HBV screening, including 36 from the candidate-matched
controls,52fromthefamilymembersand25fromtheunmatched
controls from the source population.
After giving written informed consent, residents who agreed
to participate completed a questionnaire and provided blood
samples.
Epidemiological investigation
Patients with AHB and the controls were interviewed by trained
research assistants using a standard, two-page questionnaire
requesting information up to 6 months before the diagnosis of
AHB. Information regarding sociodemographic characteristics,
immunisation history, and exposures to known and potential
risk factors for HBV infection was collected retrospectively. All
participants were examined for HBV serological markers,
including HBsAg, antibody to HBs (anti-HBs), hepatitis B e
antigen (HBeAg), antibody to HBe (anti-HBe) and anti-HBc.
Standard HBV vaccination with recombinant hepatitis B
vaccine (Dalian Hissen Bio-Pharm, Dalian, China) was provided
to those without HBV infection.
Laboratory analysis
During the survey, 5 ml fasting blood from all participants was
collected with a vacuum blood collection tube without antic-
oagulant. Serum samples of AHB patients during symptomatic
phase were collected from hospitals. The serum was separated
by centrifugation at 4uC and stored in a sterile tube at 280uC
within 6 h of sample collection. Serological testing was
performed as follows: HBsAg, HBeAg, anti-HBc immunoglobu-
lin G (IgG), IgM, anti-HBs, anti-HBe, and antibodies to hepatitis
C virus were examined by Architect-i2000 (Abbott Laboratories,
North Chicago, Illinois, USA). Antibodies to hepatitis A virus
and hepatitis E virus were examined by enzyme-linked
immunosorbent assay (Abbott Laboratories).
HBV DNA was extracted from 200 ml sera by using the serum
viral DNA purification kit (PG Biotechnology, Shenzhen,
China). Serum viral load was measured in the LightCycler
(Roche, Mannheim, Germany), using the Quantitative HBV
PCR Fluorogence Diagnostic Kit (PG Biotechnology, Shenzhen,
China). Genotypes of HBV were determined by using a
multiplex polymerase chain reaction (PCR) assay developed in
our laboratory
23 and confirmed by DNA sequencing.
A part of the preS and S gene region of HBV genome was
amplified by PCR and sequenced as described previously.
23 The
sequences from nt. 2919 to nt. 614 (910 base pairs) were isolated
and registered in GenBank with accession numbers from
EU216040 to EU216057. The sequences were aligned using the
BioEdit (version 7.0.0) and CLUSTAL X 1.83 algorithms with
default parameters. The phylogenetic tree was constructed by
using the neighbour-joining component of the MEGA 4.0
computer program.
24 Bootstrap analysis with 1000 replicates
was used to determine the robustness of the tree and the
evolutionary relationship of HBV.
Statistical analysis
The data were entered (double entry) and analysed using the
Statistical Program for Social Sciences (SPSS12.0 for Windows).
The x
2 test was used to determine the differences in categorical
Figure 1 Annual incidence of reported cases of acute hepatitis B in
Shanghai, China from 1993 to 2005. Approximately 17.78 million people
were surveyed.
Hepatology
1714 Gut 2008;57:1713–1720. doi:10.1136/gut.2008.157149variables. The odds ratio (OR) and 95% confidence interval (CI)
for the factors under consideration were calculated in a
univariate logistic regression analysis. To determine the factors
contributing independently to AHB, forward stepwise multi-
variate regression analysis (pentry=0.05, premoval=0.10) was
performed. The adjusted OR (AOR) for each risk factor was
estimated by the adjustments with age, sex and educational
level. Univariate and multivariate analyses were used to
determine the factors including HBV genotypes, age and sex
associated with chronicification of AHB. Serum viral load with
skewed distribution was adjusted to normal distribution by
transformation into logarithmic function, and then tested by
the Student t test. A p value ,0.05 was considered as
statistically significant.
RESULTS
General information
The mean age of the 294 patients with AHB was 41.65 (SD
12.18) years and the ratio of men to women was 3.28:1. Thirty-
six (5.77%) of the candidates matched 624 controls were
Figure 2 CONSORT flow diagram of this
study. The broken lines (- - - -) indicate
the type of epidemiological studies
between the two population groups.
HBV, hepatitis B virus.
Table 1 Univariate and multivariate analyses of the risk factors exposed within 6 months before onset of acute hepatitis B: a community-based study
Potential risk factor Cases Controls OR (95% CI) AOR (95% CI)
Household contact with HBV carriers 101 (34.35) 89 (15.14) 2.93 (2.11 to 4.08) 3.05 (2.11 to 4.41)*
Spouse with HBV infection 21 (7.14) 25 (4.25) 1.73 (0.92 to 3.27)
Mother with HBV infection 12 (4.08) 5 (0.85) 4.96 (1.73 to 14.22) 4.25 (1.11 to 16.22){
Other members with HBV infection 45 (15.31) 24 (4.08) 4.23 (2.53 to 7.13) 3.64 (1.97 to 6.75){
Family member with liver cirrhosis 18 (6.12) 5 (0.85) 7.60 (2.68 to 26.41) 4.04 (1.28 to 12.78){
Family member with HCC 11 (3.74) 8 (1.36) 2.82 (1.04 to 7.76)
Sharing razor 8 (2.72) 6 (1.02) 2.71 (0.82 to 9.57)
Sharing towels 30 (10.20) 38 (6.46) 1.64 (0.97 to 2.79)
Invasive medical procedure 103 (35.03) 77 (13.10) 3.56 (2.55 to 5.02) 3.72 (2.55 to 5.42)*
Surgery 12 (4.08) 9 (1.53) 2.74 (1.06 to 7.14)
Endoscopy 10 (3.40) 7 (1.19) 2.92 (1.01 to 8.60)
Intravenous injection or infusion 78 (26.53) 56 (9.52) 3.43 (2.31 to 5.10) 2.53 (1.52 to 4.21){
Intramuscular injection 61 (20.75) 40 (6.80) 3.59 (2.29 to 5.62) 2.17 (1.22 to 3.84){
Body care and beauty treatments in public places 130 (44.22) 155 (26.36) 2.21 (1.65 to 2.97) 1.52 (1.09 to 2.12)*
Barber shop shaving (>4 times) 58 (19.73) 76 (12.93) 1.66 (1.12 to 2.45)
Receiving pedicure in the bath centre 103 (35.03) 102 (17.35) 2.55 (1.85 to 3.51) 1.98 (1.36 to 2.87){
No 191 486
Once 31 50 1.58 (0.95 to 2.61)
Two to three times 21 28 1.91 (1.02 to 3.57)
Four times or more 51 24 5.41 (3.15 to 9.33)
Eating out (twice or more/week) 93 (31.63) 69 (11.73) 3.48 (2.41 to 5.02) 3.20 (2.14 to 4.77)*
Lack of HBV vaccination 285 (96.94) 484 (82.31) 6.80 (3.28 to 14.62) 7.78 (3.76 to 16.11)*
Data are expressed as number (%).
*Variables in the multivariate model included household contact with HBV carriers, invasive medical procedure, body care/beauty treatments in public places, eating out and lack of
HBV vaccination.
{Variables in the multivariate model included mother with HBV infection, other members with HBV infection, family members with liver cirrhosis, intravenous injection or infusion,
intramuscular injection, receiving pedicure in the bath centre, eating out, and absent HBV vaccination.
AOR, adjusted odds ratio; CI, confidence interval; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; OR, odds ratio.
Hepatology
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members of AHB patients, 52 (9.09%) were found to be
HBsAg seropositive. HBsAg seropositivity in the family mem-
bers of AHB patients was higher than that of the matched
controls (p=0.028). HBV persisted in 25 (8.50%) of the 294
AHB patients. The CONSORT flow diagram is shown in fig 2.
A total of 78 patients with hepatitis A, 30 with hepatitis C,
and 147 with hepatitis E were excluded, respectively. Of these
patients, 40 with hepatitis A, 11 with hepatitis C, and 110 with
hepatitis E were HBsAg seropositive.
Risk factors for acute hepatitis B
In the univariate regression analysis, statistically significant
ORs were obtained for household contact with chronic hepatitis
B( p ,0.001), liver cirrhosis (p,0.001), and hepatocellular
carcinoma (p=0.022), undergoing invasive medical procedures
including intramuscular injection (p,0.001), intravenous injec-
tions or infusions (p,0.001), endoscopy (p=0.024), and
surgery (p=0.019), body care and beauty treatment in public
places including pedicure four or more times (p,0.001), and
barber shop shaving four or more times (p=0.008), eating out
twice or more per week (p,0.001), and lack of HBV vaccination
(p,0.001) in the patients with AHB (table 1). Piercing and
tattooing in women (OR 2.06 (95% CI 1.11 to 3.81)), bleeding
during pedicure (OR 4.29 (95% CI 1.92 to 8.55)) were also risk
factors for AHB. No associations were suggested with the other
reported risk factors, such as dental surgery, acupuncture,
haemodialysis, blood transfusion, promiscuous sexual contact,
being with a user of injectable drugs.
In multivariate regression analysis, household contact with a
person or persons with liver cirrhosis (p=0.018) and chronic
hepatitis B (p,0.001), intramuscular injection (p=0.008),
intravenous injections or infusions (p,0.001), receipt of
pedicure in bath centres (p,0.001), eating out twice or more
per week (p,0.001) and lack of HBV vaccination (p,0.001)
were independently associated with AHB.
In evaluating potential relationships among eating out and
other risk factors, and their impact on AHB, eating out was
frequently found to be related to the receipt of pedicure in the
bath centres. In the patients with AHB, 53.8% of those eating
out received pedicure in bath centres, while the percentage was
only 34.8% in the controls (p=0.017). As shown in table 2,
receiving pedicure in bath centres after dinner parties played a
role in HBV transmission.
Genotype distribution
Serum samples of 128 patients with AHB were collected from
five major hospitals where AHB was diagnosed. Age and gender
composition of the 128 patients was similar to the 294 patients
involved in this study (p.0.05 for each). Sixty-eight of the 128
patients were genotyped including 33 (22 men, 11 women) with
HBV B2 and 35 (33 men, two women) with HBV C2. In acute
resolving hepatitis B, the serum viral load usually declines
rapidly due to vigorous immune response.
25 Seven (two with
HBV B2, five with HBV C2) of the 68 patients progressed into
chronic infection. HBV genotypes were determined in 107 of the
113 neighbourhood ASCs The proportion of HBV B2 was
significantly higher in the patients with AHB than in ASC
(fig 3A). The proportion of women in AHB patients with HBV
Table 2 Effect of eating out and receiving pedicure services in the bath
centres on acute hepatitis B
Eating out Pedicure Cases Controls OR (95% CI)
No No 148 (50.3) 439 (74.6)
Yes 53 (18.1) 80 (13.6) 1.97 (1.70 to 2.97)
Yes No 43 (14.6) 45 (7.7) 2.83 (1.75 to 4.59)
Yes 50 (17.0) 24 (4.1) 6.18 (3.59 to 10.84)
Data are given as the number (%). CI, confidence interval; OR, odds ratio.
Figure 3 Distributions of genotypes (A), gender (B), and age (C)
between 68 patients with acute hepatitis B (AHB) and 107
neighbourhood asymptomatic HBsAg carriers (ASCs). Age data were
expressed as mean with the SD. B2, hepatitis B virus B2; C2, hepatitis B
virus C2; F, female; M, male.
Hepatology
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the proportion of men in the neighbourhood ASCs with HBV
B2 was significantly higher than in those with HBV C2 (fig 3B).
Furthermore, the patients with HBV B2 were significantly
younger than those with HBV C2 (27.23 (SD 4.28) vs 45.69 (SD
7.02) years, p,0.001) (fig 3C). It is inferred that HBV B2 is
transmitted from men to women by sexual activity.
Twenty-five (20 with HBV C2, five with HBV B2) of the 294
patients progressed to chronic infection. The patients with HBV
C2 developed chronic infection significantly more often than
those infected with HBV B2 (p=0.013). In multivariate
analysis, 25 patients who progressed to chronic infection were
compared with 61 HBV-genotyped patients who had not
progressed to chronic infection, HBV C2 was found to be a
unique independent factor for the chronicification after adjust-
ments with age and sex (table 3).
Serum viral load and HBeAg status
Because sera from the patients with AHB did not suffice for all
assays, serum viral load from only one-third of the samples was
tested by quantitative PCR. The viral loads varied dramatically.
Constant serum viral load was determined in 107 of the 113
ASCs. Serum viral load (6.40 (SD 1.82) log10 copies/ml) in ASCs
with HBV B2 was significantly higher than the viral load (4.89
(SD 2.13) log10 copies/ml) in ASCs with HBV C2 (fig 4A).
In the 68 AHB patients with HBV genotyped, no difference in
seropositivity of HBeAg was determined between the patients
with HBV B2 (39.39%) and those with HBV C2 (34.29%). In the
25 patients who progressed to chronic infection, seropositivity
of HBeAg was 45% and 80% in those with HBV C2 and HBV
B2, respectively. No statistical differences in seropositivities of
HBeAg were determined between AHB patients and those who
progressed to chronic infection, neither in those with HBV B2
nor in those with HBV C2. However, seropositivity of HBeAg in
the neighbourhood ASC with HBV B2 (70.00%) was signifi-
cantly higher than that in those with HBV C2 (37.93%) (fig 4B).
Phylogenetic relationship of HBV intrafamilial transmission
In preliminary phylogenetic analysis, household contact with
HBV infectants might be supported by corresponding phyloge-
netic clusters (data not shown). Phylogenetic analysis was then
used to determine intrafamilial transmission. Of the 68 AHB
patients, eight cases (index: family 1) and their available family
members seropositive for HBsAg were included in this assay.
Distinct clusters of HBV C2, but not HBV B2, were defined at
the family level, including families 2, 5 and 6 and maybe 1 and 8
(fig 5). HBV B2 was identified in the index case of family 4,
while this HBsAg positive family member was HBV C1. Thus,
household transmission was frequently identified in patients
with HBV C2.
DISCUSSION
In Shanghai, a developed area of China, residents routinely
receive HBV screening. Most adults have been tested for HBV
markers and have these results documented in their medical
records. In this study, apart from serological and clinical
chemistry parameters, medical records were used to discrimi-
nate newly acquired AHB from acute exacerbation of chronic
Table 3 Univariate and multivariate regression analyses of the risk factors for chronicification of acute
hepatitis B in the patients with hepatitis B virus (HBV) genotyped
Progression to
infection*
Without
progression{ OR (95% CI) AOR (95% CI)
Sex
Male 19 50
Female 6 11 1.44 (0.47 to 4.43) 2.61 (0.71 to 9.58)
Age (years)
(40 11 36
.40 14 25 1.83 (0.72 to 4.69) 0.66 (0.19 to 2.23)
Genotype
B2 5 31
C2 20 30 4.13 (1.37 to 12.43) 6.97 (1.59 to 30.63)
*Progression to chronic HBV infection (n=25). {Without chronic HBV progression (n=61)
AOR, adjusted odds ratio; CI, confidence interval; OR, odds ratio.
Figure 4 Comparison of serum viral
load (A) and hepatitis B e antigen
(HBeAg) seropositivity (B) between 20
asymptomatic HBsAg carriers (ASCs)
with HBV B2 and 87 ASCs with HBV C2.
Serum viral load was transformed into a
logarithmic function and expressed as
mean with the SD. HBsAg, hepatitis B
surface antigen; HBV, hepatitis B virus.
Hepatology
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were excluded. Controls were randomly recruited from the
source population from which the cases arose, and matched to
the cases by sex and date of birth. Controls were obtained
without regard to exposure. To promote participation, standard
HBV vaccination was given to those seronegative for HBsAg. A
pilot study had been carried out to estimate the sample sizes.
This case–control study is reliable.
Undergoing invasive medical procedure, receiving body care
and beauty treatments in public places, household contact with
HBV-associated diseases and lack of HBV vaccination were
current risk factors for adult AHB. The enforced use of
disposable syringes for injection has been in place for many
years in China. During the survey, we observed that nurses
usually did not change their gloves when giving injections or
changing bandages after surgery between patients, especially in
primary hospitals. These unsatisfactory procedures may con-
tribute to nosocomial transmission of HBV.
Among these risk factors, receiving pedicures in bath centres
was emerging. Recently, bath centres which provide pedicure
and even hidden sex services have been developing. The health
condition of the service professionals and the disinfection
situation of the instruments used for the invasive procedures
are usually not controlled by local public health agencies. The
potential for transmission of infectious diseases exists when
receiving manicures and pedicures in urban settings.
26
Surprisingly, the frequency of eating out was found to be an
independent risk factor for AHB. An association of HBV
transmission with the consumption of raw seafood has been
reported in Korea.
27 In this present study, we demonstrated that
eating out may be an indicator of other exposure-prone
behaviours rather than an actual risk factor for AHB (table 2).
In China, promiscuous sexual contact is considered immoral
and drug injection is illegal. Some participants refused to
provide information concerning promiscuous sexual contact or
being users of injectable drugs or cohabiting with drug users,
resulting in a probable underestimation of these exposures.
In this study, 8.50% of the patients with AHB progressed to
chronic infection. Other studies reported rates of 0.2% in
Greece, 1% in Japan, 2.7% in Taiwan, 10.4% in Alaskan Inuit,
and 8.1% or 12.1% in Germany.
18 28–32 We found different rates
of HBV B2 and HBV C2 in AHB and ASC (fig 3A). In ASCs,
81.3% was HBV C2 and 18.7% was HBV B2. The rates were
very similar to the figures reported already for chronic HBV
Figure 5 Phylogenetic analysis of the
preS and S region of hepatitis B virus
(HBV) in eight families (families 1–8) with
an index acute hepatitis B (family 1) and
the family members. The phylogenetic
tree was constructed by using the
neighbour-joining component of the
MEGA 4.0 computer program. Bootstrap
values are shown along each main
branch. The sequences of HBV preS and S
region obtained from the GenBank
database were compared with the same
region of HBV isolated in this study. The
length of the horizontal bars indicates the
number of nucleotide substitutions per
site.
Hepatology
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33 The key result of this study is that
HBV C2 was more prone to chronic progression than HBV
B2. Gender and age may be determinants of the chronicifica-
tion because the patients with HBV C2 were much more
likely to be older men (fig 3C). In multivariate analysis, HBV
C2 was confirmed to be an independent factor for AHB
chronicity, while gender and age was not (table 3). Although
we did not find any difference in viral load and HBeAg
status between the patients with HBV B2 and those with
HBV C2, these differences between the neighbourhood ASC
with HBV B2 and those with HBV C2 were apparent (fig 4).
High concentrations of HBV DNA were found in saliva,
semen, nasopharyngeal fluid, urine and tears of ASCs with
high viral load,
34–36 indicating that exposure to these fluids
may lead to infection. The higher virus load may have
contributed to the more frequent transmission of HBV B2.
However, it did not cause a higher rate of chronicity. Higher
rate of persistence was not due to higher viral DNA
concentrations of HBV C2 in ASC, in contrast to HBV B2
(fig 4A). HBeAg is involved in evading the immune
response.
37 38 Thus, HBeAg expression was expected to be
associated with transition to chronicity. Surprisingly, there
were no differences in HBeAg expression in our AHB patients
with or without resolution for both HBV B2 and HBV C2.
Thus, the only factor identified as a risk factor for
chronicification of AHB in our study remains HBV C2.
Interestingly, AHB patients with HBV B2 were much
younger, with a higher proportion of women than those with
HBV C2. ASC with HBV B2 showed a higher viral load, higher
HBeAg status, and higher proportion in men than those with
HBV C2. This molecular evidence indicates that heterosexual
activity was the most likely transmission route of HBV B2
although this risk factor was not revealed by the field
epidemiological study.
Phylogenetic analysis showed that distinct clusters of HBV
C2 were defined at the family level. Household contact with
HBV-positive family members is one of the most likely
transmission routes of HBV C2. Interestingly, we found a
family member with HBV C1, which is frequently found in
southern China. In Shanghai and its surrounding area, HBV C1
is very rare.
15
Major risk factors suggested in this study should be useful
in conducting public health interventions for the prevention
and control of AHB. If we take into account all the data from
this study, an important academic conclusion is that there are
inherent – as yet unknown – properties encoded in HBV C2
that lead to higher persistence after acute infection. The
identification of the properties of HBV C2 that lead to
immune evasion may improve our understanding of the viral
life cycle and enable strategies to break immune tolerance
induced by HBV.
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ANSWER
From the question on page 1665
Colocutaneous fistula is a rare complication of percutaneous
endoscopic gastrostomy (PEG) tube placement.
12In this case,
the injection of water-soluble contrast medium via the PEG tube
caused opacification of the transverse colon, and the contrast
medium passed smoothly to the distal colon (fig 1 of the
question). Subsequent CT scan showed the tip of the feeding
tube in the lumen of the mid-transverse colon (fig 2). The PEG
tube was withdrawn from the transverse colon using colono-
scopy (fig 1A), and the hole was sealed with haemoclips (fig 1B).
Faecal material in a PEG tube and diarrhoea after feeding are
two signs that should alert clinicians to the possibility of PEG
tube misplacement into the colon.
3 Two possible mechanisms
have been proposed for colocutaneous fistula.
3 One is the
formation of gastrocolic fistula. During the initial procedure of
PEG tube insertion, the needle passes through a segment of
colon (especially in the transverse colon) before it enters the
stomach. Then, the tube dislodges into the colon. The other
mechanism is due to the erosions of the gastric wall into the
colon caused by the pressure of the tube bumper. In the cases of
previous abdominal surgery, clinical history of megacolon as
well as subphrenic transposition of the colon, doctors should
keep a high index of suspicion to avoid transcolonic insertion of
the needle.
3
Careful endoscopic technique with trans-illumination is
mandatory when placing a PEG tube. It is crucial to avoid
insufflating large amounts of air into the stomach during the
procedure, as it can cause gastric rotation and pull transverse
colon into the stomach.
23 In addition, the direct endoscopic
observation of the imprint of a finger pressed on the skin and
the absence of any air aspirated through a small-gauge
anesthetic needle during insertion are also fundamental to
ensure the percutaneous puncture does not pass through the
colon and risk creating a colocutaneous fistula.
3
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Figure 1 (A) A colonoscopic view of the
transverse colon. (B) The hole is sealed
with haemoclips.
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